After all, the market solves everything, so the sale of the UK’s primary blood plasma supplier to Bain Capital should work out just fine:

The Government was tonight accused of gambling with the UK’s blood supply by selling the state-owned NHS plasma supplier to a US private equity firm.

The Department of Health overlooked several healthcare or pharmaceutical firms and at least one blood plasma specialist before choosing to sell an 80 per cent stake in Plasma Resources UK to Bain Capital, the company co-founded by Republican presidential candidate Mitt Romney, in a £230m deal. The Government will retain a 20 per stake and a share of potential future profits.

PRUK has annual sales of around £110m and consists of two companies: it employs 200 people at Bio Products Laboratory (BPL) in Elstree, Hertfordshire, and more than 1,000 at DCI Biologicals Inc in the US. DCI collects plasma from American donors and sends it to BPL where it is separated into blood proteins, clotting factors and albumin for supply to NHS hospitals in the treatment of immune deficiencies, neurological diseases, and haemophilia.

Considering the damage caused in the US because the American Red Cross (under the direction of Liddy Dole) and big pharma, both of whom resisted 100% testing for years,and  killed tens of thousands of hemophiliacs in the United States, and many times that world wide, this does not fill em with confidence about the UK blood supply.